COMMUNIQUÉS West-GlobeNewswire

Investor meeting on May 3, 2018.

02/05/2018 - 09:39

In connection with the release of BioPorto’s interim report covering the first quarter of 2018, BioPorto will hold an investor meeting on May 3, 2018 at 3 pm. at Tuborg Havnevej 15, st, 2900 Hellerup, Denmark. [...]

Notification from Oasmia Pharmaceutical AB

02/05/2018 - 08:45

Oasmia Pharmaceutical AB hereby issues a notification that the Company has submitted a Form F-3 to SEC which is a required document in case the Company would need to do a financial transaction in the US during the [...]

Novo Nordisk's operating profit decreased by 8% in Danish kroner and increased by 6% in local currencies in the first three months of 2018

02/05/2018 - 07:32

Sales decreased by 5% in Danish kroner and increased by 5% in local currencies to DKK 26.9 billion. Sales of Victoza® increased by 4% to DKK 6.0 billion (18% in local currencies). Sales of Tresiba® increased by 18% to [...]

Targovax announces early signal of efficacy in ONCOS-102 trial in mesothelioma

02/05/2018 - 07:01

Responses observed in three out of six patients Recruitment into the randomized part of the trial underway Oslo, Norway, 2 May 2018 - Targovax ASA (OSE: TRVX), a clinical stage company focused on developing immuno- [...]

Interim Report Q1 2018: Double digit organic growth drives strong EBITA margin increase. GN Audio upgrades organic growth guidance

02/05/2018 - 07:00

GN Store Nord delivered 10% organic revenue growth in Q1 2018. Revenue growth was 3% including around (7)% impact from development in foreign exchange rates EBITA margin increased 1.1 percentage points in Q1 2018 [...]

Initiation of new share buyback program

02/05/2018 - 06:53

Based on the continued solid business performance and GN’s capital structure policy and in accordance with the authorization granted to the Board of Directors at the annual general meeting on 13 March 2018, GN announces [...]

BeiGene Appoints Senior Pharmaceutical Executive Dr. Xiaobin Wu as General Manager of China and President of BeiGene, Ltd.

02/05/2018 - 01:00

BEIJING, China and CAMBRIDGE, Mass., May 01, 2018 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: BGNE ), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly targeted [...]

REVA to Hold First Quarter 2018 Financial Results Call

02/05/2018 - 00:57

SAN DIEGO, May 01, 2018 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) (“REVA” or the “Company”) has scheduled a conference call to review its first quarter 2018 financial results and provide a business update. The [...]

Onconova Therapeutics Announces Closing of $28.75 Million Upsized Underwritten Public Offering

02/05/2018 - 00:33

Underwriter’s Option to Purchase Additional Securities Exercised in Full NEWTOWN, Pa., May 01, 2018 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX ) (“Onconova” or “we”), a Phase 3 stage biopharmaceutical [...]

IntelGenx Announces Proposed Private Placement

01/05/2018 - 23:25

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES SAINT LAURENT, Quebec, May 01, 2018 (GLOBE NEWSWIRE) -- IntelGenx [...]

Aeterna Zentaris to Announce First Quarter 2018 Financial and Operating Results on May 7, 2018

01/05/2018 - 23:05

CHARLESTON, S.C., May 01, 2018 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS ) (TSX: AEZS ) will announce its first quarter 2018 financial and operating results after market close on Monday, May 7, 2018. The [...]

National Research Corporation Announces First Quarter 2018 Results

01/05/2018 - 23:00

Company Pivots Clients to Digital Voice of Customer (VOC) Platform LINCOLN, Neb., May 01, 2018 (GLOBE NEWSWIRE) -- National Research Corporation (NASDAQ: NRC ) today announced results for the first quarter of 2018. [...]

Harvard Bioscience Subsidiary Multi Channel Systems Launches Beta Cell Screening System for Diabetes Research, Entering New Segment of Electrophysiology Market

01/05/2018 - 23:00

Multi-Electrode Array (MEA) Offers New Route for Type 2 Diabetes Drug Development and Ability to Elucidate Beta Cell Pathophysiology HOLLISTON, Mass., May 01, 2018 (GLOBE NEWSWIRE) -- Multi Channel Systems (MCS), a [...]

Intercept to Announce First Quarter 2018 Financial Results on May 8, 2018 and Present at Upcoming Investor Conferences

01/05/2018 - 23:00

NEW YORK, May 01, 2018 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT ), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non- [...]

Zogenix Reports Granting of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

01/05/2018 - 23:00

EMERYVILLE, Calif., May 01, 2018 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq: ZGNX ), a pharmaceutical company developing therapies for the treatment of rare central nervous system (CNS) disorders, today announced that it [...]

Immunovaccine Shareholders Approve Share Consolidation at 99.85%

01/05/2018 - 22:35

HALIFAX, Nova Scotia, May 01, 2018 (GLOBE NEWSWIRE) -- Immunovaccine Inc. (TSX: IMV )(OTCQX:IMMVF), a clinical stage immuno-oncology corporation, today announced that at the annual and special meeting of shareholders [...]

Harvard Bioscience Subsidiary Data Sciences International Launches Two Telemetry Implants to Enhance Neuroscience Research

01/05/2018 - 22:30

PhysioTel™ Digital L03 and L04 Designed to Improve Animal Welfare in Large Animal Models ST. PAUL, Minn. and HOLLISTON, Mass., May 01, 2018 (GLOBE NEWSWIRE) -- Data Sciences International (DSI), a subsidiary of Harvard [...]

Assure Holdings Corp. Announces Update

01/05/2018 - 22:30

PARKER, Colo., May 01, 2018 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “ Company ” or “ Assure ”) (TSXV:IOM) (OTCQB:ARHH) is announcing that the Company has applied for and received a Management Cease Trade Order (“ [...]

Teligent, Inc. to Present at Deutsche Bank’s 43rd Annual Health Care Conference on Tuesday May 8, 2018

01/05/2018 - 22:30

BUENA, N.J., May 01, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT ), a New Jersey based specialty generic pharmaceutical company, will be presenting at Deutsche Bank’s 43 rd Annual Health Care Conference. The [...]